Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AMRX
AMRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AMRX News
Amneal Pharmaceuticals Q1 2026 Earnings Exceed Expectations
May 08 2026
seekingalpha
Analysis of Risks and Opportunities in Value Stock Investment
May 04 2026
Yahoo Finance
Amneal Pharmaceuticals Q1 Earnings Preview
Apr 30 2026
seekingalpha
Amneal Pharmaceuticals Acquires Kashiv BioSciences, Paving the Way for Biosimilars Integration
Apr 22 2026
seekingalpha
U.S. Stocks Rise, Nasdaq Hits Record High
Apr 22 2026
NASDAQ.COM
U.S. Stocks Rise, Nasdaq Hits Record High
Apr 22 2026
NASDAQ.COM
Amneal Acquires Kashiv BioSciences for $750M, Boosts Revenue Guidance
Apr 22 2026
seekingalpha
Amneal to Acquire Kashiv, Creating a Global Biosimilars Platform
Apr 22 2026
Newsfilter
Amneal Acquires Kashiv BioSciences to Capitalize on $300B Global Biologics Market
Apr 22 2026
Newsfilter
UBS Initiates Buy Rating on Amneal Pharmaceuticals with $19 Price Target
Apr 20 2026
seekingalpha
Latest Ratings and Outlook from Wall Street
Apr 17 2026
CNBC
Amneal Pharmaceuticals Reports Strong Q4 2025 Earnings Growth and Strategic Outlook
Feb 27 2026
seekingalpha
Amneal Pharmaceuticals Q4 Earnings Beat Expectations with Strong Revenue Growth
Feb 27 2026
Benzinga
Amneal Pharmaceuticals Q4 Earnings Exceed Expectations
Feb 27 2026
seekingalpha
Amneal Pharmaceuticals Set to Release Q4 Earnings on February 27
Feb 26 2026
seekingalpha
Doseology Sciences Launches New Energy Product Line
Feb 13 2026
PRnewswire
Show More News
